Article
Role of ferroptosis in hepatocellular carcinoma.
Journal of cancer research and clinical oncology - 1 Dec 2018
Nie Jianhua, Lin Binlin, Zhou Meng, Wu Li, Zheng Tongsen
Abstract excerpt
PURPOSE: Hepatocellular carcinoma (HCC) is a complicated disease with low survival rate due to frequent recurrence and the lack of efficient therapies. For advanced HCC, sorafenib, as the only approved first-line drug for HCC, improves the survival to some extent, but depressingly with severe adverse effects and emerging resistance conditions, which cause a poor prognosis. Ferroptosis is a new recognized way of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
